{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:51:33Z","timestamp":1791244293740,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hiroshima University subsidy for the Genomic Medicine Center Ryokufukai Encouragement Award for Education and Research, Grant-in-Aid for Young Investigator"},{"name":"Ryokufukai Encouragement Award for Education and Research, Grant-in-Aid for Young Investigato"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41431-026-02058-1","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T03:22:13Z","timestamp":1772421733000},"page":"1104-1111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A prioritization framework for BRCA1\/2 variants of uncertain significance identified by comprehensive genomic profiling"],"prefix":"10.1038","volume":"34","author":[{"given":"Hikaru","family":"Nakahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6878-9712","authenticated-orcid":false,"given":"Hiroaki","family":"Niitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Toshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khilola Madaminovna","family":"Saipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Nelson","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-6812","authenticated-orcid":false,"given":"Nobuyuki","family":"Hinata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Hinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2058_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41576-021-00338-8","volume":"22","author":"D Chakravarty","year":"2021","unstructured":"Chakravarty D, Solit DB. Clinical cancer genomic profiling. Nat Rev Genet. 2021;22:483\u2013501. https:\/\/doi.org\/10.1038\/s41576-021-00338-8.","journal-title":"Nat Rev Genet"},{"key":"2058_CR2","doi-asserted-by":"publisher","unstructured":"Ebi H,Bando H Precision Oncology and the Universal Health Coverage System in Japan. JCO Precis Oncol 2019;3, https:\/\/doi.org\/10.1200\/po.19.00291.","DOI":"10.1200\/po.19.00291"},{"key":"2058_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2183\/pjab.96.023","volume":"96","author":"H Mano","year":"2020","unstructured":"Mano H. Cancer genomic medicine in Japan. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96:316\u201321. https:\/\/doi.org\/10.2183\/pjab.96.023.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2058_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/cas.14754","volume":"112","author":"Y Mukai","year":"2021","unstructured":"Mukai Y, Ueno H. Establishment and implementation of Cancer Genomic Medicine in Japan. Cancer Sci. 2021;112:970\u20137. https:\/\/doi.org\/10.1111\/cas.14754.","journal-title":"Cancer Sci"},{"key":"2058_CR5","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1111\/cas.15586","volume":"113","author":"H Ida","year":"2022","unstructured":"Ida H, Koyama T, Mizuno T, Sunami K, Kubo T, Sudo K, et al. Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice. Cancer Sci. 2022;113:4300\u201310. https:\/\/doi.org\/10.1111\/cas.15586.","journal-title":"Cancer Sci"},{"key":"2058_CR6","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1111\/cas.15993","volume":"114","author":"I Fukada","year":"2023","unstructured":"Fukada I, Mori S, Hayashi N, Hosonaga M, Xiaofei W, Yamazaki M, et al. Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice. Cancer Sci. 2023;114:4632\u201342. https:\/\/doi.org\/10.1111\/cas.15993.","journal-title":"Cancer Sci"},{"key":"2058_CR7","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1111\/cas.15517","volume":"113","author":"K Sunami","year":"2022","unstructured":"Sunami K, Naito Y, Komine K, Amano T, Ennishi D, Imai M, et al. Chronological improvement in precision oncology implementation in Japan. Cancer Sci. 2022;113:3995\u20134000. https:\/\/doi.org\/10.1111\/cas.15517.","journal-title":"Cancer Sci"},{"key":"2058_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrc.2016.72","volume":"16","author":"FC Nielsen","year":"2016","unstructured":"Nielsen FC, van Overeem Hansen T, S\u00f8rensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer. 2016;16:599\u2013612. https:\/\/doi.org\/10.1038\/nrc.2016.72.","journal-title":"Nat Rev Cancer"},{"key":"2058_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N Engl J Med. 2017;377:523\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1706450.","journal-title":"N Engl J Med"},{"key":"2058_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-018-0009-7","volume":"24","author":"A Tutt","year":"2018","unstructured":"Tutt A, Tovey H, Cheang MCU, Kernaghan S, Kilburn L, Gazinska P, et al. Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nat Med. 2018;24:628\u201337. https:\/\/doi.org\/10.1038\/s41591-018-0009-7.","journal-title":"Nat Med"},{"key":"2058_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"key":"2058_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20146-8","volume":"12","author":"J Takayama","year":"2021","unstructured":"Takayama J, Tadaka S, Yano K, Katsuoka F, Gocho C, Funayama T, et al. Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference. Nat Commun. 2021;12:226. https:\/\/doi.org\/10.1038\/s41467-020-20146-8.","journal-title":"Nat Commun"},{"key":"2058_CR13","doi-asserted-by":"publisher","first-page":"D835","DOI":"10.1093\/nar\/gkz972","volume":"48","author":"MJ Landrum","year":"2020","unstructured":"Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucl Acids Res. 2020;48:D835\u2013d844. https:\/\/doi.org\/10.1093\/nar\/gkz972.","journal-title":"Nucl Acids Res"},{"key":"2058_CR14","doi-asserted-by":"publisher","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J et al. OncoKB: A Precision Oncology Knowledge Base. JCO Precis Oncol 2017, https:\/\/doi.org\/10.1200\/po.17.00011.","DOI":"10.1200\/po.17.00011"},{"key":"2058_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100:267\u201380. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.004.","journal-title":"Am J Hum Genet"},{"key":"2058_CR16","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35:1978\u201380. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897.","journal-title":"Bioinformatics"},{"key":"2058_CR17","doi-asserted-by":"publisher","unstructured":"Yamaguchi M, Akabane S, Niitsu H, Nakahara H, Toshida A, Mochizuki T et al. The usefulness of comprehensive genome profiling test in screening of Lynch syndrome independent of the conventional clinical screening or microsatellite instability tests. J Hum Genet 2025 https:\/\/doi.org\/10.1038\/s10038-025-01345-x.","DOI":"10.1038\/s10038-025-01345-x"},{"key":"2058_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"key":"2058_CR19","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","volume":"111","author":"MT Parsons","year":"2024","unstructured":"Parsons MT, de la Hoya M, Richardson ME, Tudini E, Anderson M, Berkofsky-Fessler W, et al. Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel. Am J Hum Genet. 2024;111:2044\u201358. https:\/\/doi.org\/10.1016\/j.ajhg.2024.07.013.","journal-title":"Am J Hum Genet"},{"key":"2058_CR20","doi-asserted-by":"publisher","unstructured":"Ha C, Kim JW, Jang JH Performance Evaluation of SpliceAI for the Prediction of Splicing of NF1 Variants. Genes. 2021;12, https:\/\/doi.org\/10.3390\/genes12091308.","DOI":"10.3390\/genes12091308"},{"key":"2058_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03144-z","volume":"24","author":"C Smith","year":"2023","unstructured":"Smith C, Kitzman JO. Benchmarking splice variant prediction algorithms using massively parallel splicing assays. Genome Biol. 2023;24:294. https:\/\/doi.org\/10.1186\/s13059-023-03144-z.","journal-title":"Genome Biol"},{"key":"2058_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ajhg.2024.02.002","volume":"111","author":"C Hu","year":"2024","unstructured":"Hu C, Huang H, Na J, Lumby C, Abozaid M, Holdren MA, et al. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain. Am J Hum Genet. 2024;111:584\u201393. https:\/\/doi.org\/10.1016\/j.ajhg.2024.02.002.","journal-title":"Am J Hum Genet"},{"key":"2058_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-024-08388-8","volume":"638","author":"H Huang","year":"2025","unstructured":"Huang H, Hu C, Na J, Hart SN, Gnanaolivu RD, Abozaid M, et al. Functional evaluation and clinical classification of BRCA2 variants. Nature. 2025;638:528\u201337. https:\/\/doi.org\/10.1038\/s41586-024-08388-8.","journal-title":"Nature"},{"key":"2058_CR24","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-024-08349-1","volume":"638","author":"S Sahu","year":"2025","unstructured":"Sahu S, Galloux M, Southon E, Caylor D, Sullivan T, Arnaudi M, et al. Saturation genome editing-based clinical classification of BRCA2 variants. Nature. 2025;638:538\u201345. https:\/\/doi.org\/10.1038\/s41586-024-08349-1.","journal-title":"Nature"},{"key":"2058_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","volume":"562","author":"GM Findlay","year":"2018","unstructured":"Findlay GM, Daza RM, Martin B, Zhang MD, Leith AP, Gasperini M, et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562:217\u201322. https:\/\/doi.org\/10.1038\/s41586-018-0461-z.","journal-title":"Nature"},{"key":"2058_CR26","doi-asserted-by":"publisher","unstructured":"Bose M, Singh MI, Fr\u00f6din M, Ejlertsen B, S\u00f8rensen CS,Rossing M Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects. J Clin Invest 2025 https:\/\/doi.org\/10.1172\/jci181879.","DOI":"10.1172\/jci181879"},{"key":"2058_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41436-018-0052-2","volume":"21","author":"RLS Mesman","year":"2019","unstructured":"Mesman RLS, Call\u00e9ja F, Hendriks G, Morolli B, Misovic B, Devilee P, et al. The functional impact of variants of uncertain significance in BRCA2. Genet Med. 2019;21:293\u2013302. https:\/\/doi.org\/10.1038\/s41436-018-0052-2.","journal-title":"Genet Med"},{"key":"2058_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","volume":"8","author":"Y Momozawa","year":"2022","unstructured":"Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, et al. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants. JAMA Oncol. 2022;8:871\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0476.","journal-title":"JAMA Oncol"},{"key":"2058_CR29","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1111\/cas.15799","volume":"114","author":"K Yamazawa","year":"2023","unstructured":"Yamazawa K, Sugano K, Tanakaya K, Inoue S, Murakami H, Nakashima M, et al. The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition. Cancer Sci. 2023;114:2993\u20133002. https:\/\/doi.org\/10.1111\/cas.15799.","journal-title":"Cancer Sci"},{"key":"2058_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ajhg.2024.12.011","volume":"112","author":"L Ramadane-Morchadi","year":"2025","unstructured":"Ramadane-Morchadi L, Rotenberg N, Esteban-S\u00e1nchez A, Fortuno C, G\u00f3mez-Sanz A, Varga MJ, et al. ACMG\/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3\/BP4 computational evidence. Am J Hum Genet. 2025;112:993\u20131002. https:\/\/doi.org\/10.1016\/j.ajhg.2024.12.011.","journal-title":"Am J Hum Genet"},{"key":"2058_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41431-025-01881-2","volume":"33","author":"MP Buisine","year":"2025","unstructured":"Buisine MP, Bellanne-Chantelot C, Calmels N, Vach\u00e9 C, Besnard T, Cogne B, et al. RNA-based diagnostic studies in genetics: Review and guidance from a multidisciplinary French network. Eur J Hum Genet. 2025;33:1219\u201327. https:\/\/doi.org\/10.1038\/s41431-025-01881-2.","journal-title":"Eur J Hum Genet"},{"key":"2058_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cancergencyto.2006.05.005","volume":"170","author":"F Bonatti","year":"2006","unstructured":"Bonatti F, Pepe C, Tancredi M, Lombardi G, Aretini P, Sensi E, et al. RNA-based analysis of BRCA1 and BRCA2 gene alterations. Cancer Genet Cytogenet. 2006;170:93\u2013101. https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.05.005.","journal-title":"Cancer Genet Cytogenet"},{"key":"2058_CR33","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/humu.22101","volume":"33","author":"C Houdayer","year":"2012","unstructured":"Houdayer C, Caux-Moncoutier V, Krieger S, Barrois M, Bonnet F, Bourdon V, et al. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat. 2012;33:1228\u201338. https:\/\/doi.org\/10.1002\/humu.22101.","journal-title":"Hum Mutat"},{"key":"2058_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s10038-023-01194-6","volume":"68","author":"Q Guo","year":"2023","unstructured":"Guo Q, Ji S, Takeuchi K, Urasaki W, Suzuki A, Iwasaki Y, et al. Functional evaluation of BRCA1\/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model. J Hum Genet. 2023;68:849\u201357. https:\/\/doi.org\/10.1038\/s10038-023-01194-6.","journal-title":"J Hum Genet"},{"key":"2058_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.gim.2021.11.018","volume":"24","author":"EH Wilcox","year":"2022","unstructured":"Wilcox EH, Sarmady M, Wulf B, Wright MW, Rehm HL, Biesecker LG, et al. Evaluating the impact of in silico predictors on clinical variant classification. Genet Med. 2022;24:924\u201330. https:\/\/doi.org\/10.1016\/j.gim.2021.11.018.","journal-title":"Genet Med"},{"key":"2058_CR36","doi-asserted-by":"publisher","unstructured":"Stella S, Vitale SR, Massimino M, Martorana F, Tornabene I, Tomarchio C et al. In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes. 2024;15, https:\/\/doi.org\/10.3390\/genes15070943.","DOI":"10.3390\/genes15070943"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02058-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:03:26Z","timestamp":1785445406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02058-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02058-1","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is nothing to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"During the preparation of this work, the authors used\n                      OpenAI\u2019s ChatGPT\n                      in order to assist with language editing and to improve clarity of expression. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Declaration of AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Hiroshima University Ethical Committee for Epidemiology (Approval numbers: E2024-0153-01, E2025-0135-00).","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}